I25
Conditions
Interventions
Group 1: This study is observational.
Sponsors
Institut für kardiovaskuläre Regeneration Zentrum für Molekulare Medizin der J.W. Goethe Universität Frankfurt / Germany
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with documented stable or unstable coronary artery disease (Acute coronary syndromes). Written informed consent and willigness to give a sample of 20ml venous blood.
Exclusion criteria
Exclusion criteria: -active Infection -pregnancy or lactation -chronic inflammatory disease (i.E. M. Crohn, Rheumatoid Arthritis) -HIV Infection oder active Hepatitis -Tumor disease without documented complete remission within the last 5 years -Stroke within the last 3 month -mental retardation -any condition, which excludes a adequate investigation of study data -participation at an other clinical study within the last 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Levels of circulating serum levels of micro RNA in patients with coronary artery disease. 1. Measurement in serum samples 2. Correlation with classical risk factors 3. Association with systemic endothelial function 4. Prognostic impact of micro RNA in patients with CAD | — |
Countries
Germany
Contacts
Public ContactStephan Fichtlscherer
Klinikum der J.W. Goethe Universität Frankfurt / Germany Abteilung für Kardiologie
Outcome results
None listed